Skin disorders
22 results
Applied filters
Preparing to use ustekinumab biosimilar
31 July 2026Introducing biosimilar ustekinumab needs planning. Work with the multidisciplinary team to ensure familiarity with the area and develop an implementation plan.
The licence and supporting evidence for ustekinumab biosimilars
31 July 2026Ustekinumab biosimilars are available for use within the NHS. Learn about indications, formulations, supporting evidence and differences.
Permethrin for scabies
21 July 2026SPS PGD template for supply of permethrin for the treatment of scabies in specified patient groups.
Malathion for scabies
21 July 2026SPS PGD template for supply of malathion for the treatment of scabies in specified patient groups.
The licence and supporting evidence for omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. Review its indications, evidence, and main differences.
Preparing to use omalizumab biosimilar
20 July 2026Adcomfo, a second omalizumab biosimilar alongside Omlyclo, is now licensed. We offer general information and implementation advice.
Doxycycline and metronidazole for human and animal bites
27 November 2025SPS PGD templates for supply of doxycycline and metronidazole for the prophylaxis of human and animal bites in specified patient groups
Co-amoxiclav for human and animal bites
27 November 2025SPS PGD template for supply of co-amoxiclav for the prophylaxis of human and animal bites in specified patient groups.
Using potassium permanganate for skin conditions or wound care
4 April 2025Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.
Treating lice during breastfeeding
31 May 2024Wet combing, dimeticone, malathion or permethrin can be used during breastfeeding; choice will depend on the indication. Other treatments can be considered.